Tetrabenazine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for tetrabenazine and what is the scope of patent protection?
Tetrabenazine
is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Apotex, Bionpharma, Chartwell Rx, Dr Reddys, Hetero Labs Ltd V, Hikma, Mylan, Slate Run Pharma, Sun Pharm, and Bausch, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.There are twelve drug master file entries for tetrabenazine. Twelve suppliers are listed for this compound.
Summary for tetrabenazine
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 12 |
NDAs: | 12 |
Drug Master File Entries: | 12 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 13 |
Patent Applications: | 3,714 |
Drug Prices: | Drug price trends for tetrabenazine |
What excipients (inactive ingredients) are in tetrabenazine? | tetrabenazine excipients list |
DailyMed Link: | tetrabenazine at DailyMed |
Recent Clinical Trials for tetrabenazine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Phase 4 |
H. Lundbeck A/S | Phase 4 |
William Ondo, MD | Phase 4 |
Pharmacology for tetrabenazine
Drug Class | Vesicular Monoamine Transporter 2 Inhibitor |
Mechanism of Action | Vesicular Monoamine Transporter 2 Inhibitors |
Medical Subject Heading (MeSH) Categories for tetrabenazine
Anatomical Therapeutic Chemical (ATC) Classes for tetrabenazine
US Patents and Regulatory Information for tetrabenazine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 209284-002 | Jan 8, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 207682-002 | Jan 31, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Slate Run Pharma | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 213316-001 | Jan 22, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Apotex | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 206093-001 | Mar 17, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 207682-001 | Jan 31, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd V | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 204574-002 | Feb 3, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.